MedTrace Logo

Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder

NCT02401854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2025-06-04

No results posted yet for this study

Summary

The ASSERT-III study aims to determine the incidence of sub-clinical (silent) atrial fibrillation (AF) among elderly patients with hypertension and at least one other risk factor for AF. This will be accomplished by monitoring with a wireless external loop monitor for 30 to 60 days.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • M-Health Solutions

    collaborator UNKNOWN

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Jeff Healey, M.D. · Population Health Research Institute

  • Stuart Connolly, M.D. · Population Health Research Institute

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02401854 on ClinicalTrials.gov